U.S. Markets closed

Aveo Pharmaceuticals CFO to resign

Aveo Pharmaceuticals disclosed in a regulatory filing that, on November 26, David Johnston, the company’s Chief Financial Officer, provided notice to AVEO of his intention to resign from the company effective as of December 30 to pursue a new career opportunity. AVEO is in the process of commencing an external search for its next CFO, the company said. Effective as of December 30, Tuan Ha-Ngoc, AVEO’s President and CEO, will assume the role of principal financial officer until a replacement CFO is appointed.